An inherited deficiency of the third component of complement, C3, in guinea pigs

Hereditary deficiency of the third component of complement, C3, is found very seldom in the human. C3 deficiency is associated with severe bacterial infections revealing the central role of C3 in complement activation via the classical or alternative pathway. We describe a new hereditary C3 deficiency in strain 2 guinea pigs. Serum from these animals had a markedly reduced lytic activity in a standard assay for complement‐dependent, antibody‐mediated cytotoxicity. In functional assays of individual components, the hemolytic activity of the components C4, C2, C5 and of factors B, D and H was in the normal range. The functional C3 titer, and similarly C3 antigenic activity in the serum of these C3‐deficient animals (C3D) was on average only 5.7% of normal activity. Typing the animals with alloantisera or monoclonal antibodies to guinea pig Ia‐antigens revealed that the C3D animals had the major histocompatibility complex‐haplotype of inbred strain 2 guinea pigs (B.1, Ia. 2,4). The C3 defect is not linked to the major histocompatibility complex and, in addition, is not linked to a C3a receptor deficiency. Macrophages and hepatocytes of the C3D animals have an unimpaired capacity for synthesis and secretion of C3 as measured by enzyme‐linked immunosorbent assay. There was no indication for hypercatabolism of normal C3 by the animals as shown by plasma clearance of 125I‐radiolabeled C3. Thrombocytes of the C3D animals responded normally to stimulation with purified C3a in an ATP‐release assay without an indication for a desensitization in vivo. Possibly the fault resides in an enhanced susceptibility of their own C3 to proteolysis. However, C3 partially purified from the plasma of the C3D animals or secreted by hepatocytes exhibited no obvious structural differences to purified normal C3 in sodium dodecyl sulfate‐polyacrylamide gel electrophoresis or in immunoblotting. The C3D serum had a reduced bactericidal activity compared to normal or to C4‐deficient serum. Nevertheless, the animals are apparently healthy without an indication for increased frequency of bacterial infections. These guinea pigs provide an unique model for analysis of the biological functions of C3 in vivo and in vitro without the need for artificial C3‐depletion procedures with all their known and unknown side‐effects.

[1]  D. Bitter‐Suermann,et al.  Monoclonal antibody detection of IncF group plasmid-encoded TraT protein in clinical isolates of Escherichia coli , 1984, Infection and immunity.

[2]  P. Densen,et al.  Complement Deficiency States and Infection: Epidemiology, Pathogenesis and Consequences of Neisserial and Other Infections in an Immune Deficiency , 1984, Medicine.

[3]  J. Schifferli,et al.  COMPLEMENT, THE IMMUNE-COMPLEX LATTICE, AND THE PATHOPHYSIOLOGY OF COMPLEMENT-DEFICIENCY SYNDROMES , 1983, The Lancet.

[4]  D. Bitter‐Suermann,et al.  Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. , 1982, Journal of immunology.

[5]  J. Weiler,et al.  Complement fragments suppress lymphocyte immune responses. , 1982, Immunology today.

[6]  D. Bitter‐Suermann,et al.  Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion , 1982, The Journal of experimental medicine.

[7]  D. Bitter‐Suermann,et al.  Linkage of total deficiency of the second component (C2) of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig. , 1981, Journal of immunology.

[8]  R. Yolken,et al.  Genetically determined deficiency of the third component of complement in the dog: in vitro studies on the complement system and complement-mediated serum activities. , 1981, Journal of immunology.

[9]  D. Bitter‐Suermann,et al.  Platelet-serotonin release by C3a and C5a: two independent pathways of activation. , 1981, Journal of immunology.

[10]  H. Colten,et al.  Genetics and biosynthesis of complement proteins. , 1981, The New England journal of medicine.

[11]  E. Shevach,et al.  Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization. , 1981, Journal of Immunology.

[12]  D. Bitter‐Suermann,et al.  Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. , 1970, Immunochemistry.

[13]  H. D. Moore Complementary and Opsonic Functions in Their Relation to Immunity , 1919, The Journal of Immunology.

[14]  G. Ramadori,et al.  Quantitative determination of complement components produced by purified hepatocytes. , 1984, Clinical and experimental immunology.

[15]  D. Bitter‐Suermann,et al.  Activation of the alternative pathway of complement: efficient fluid‐phase amplification by blockade of the regulatory complement protein β1H through sulfated polyanions , 1981, European journal of immunology.

[16]  R. Thompson,et al.  A second case of human C3b inhibitor (KAF) deficiency. , 1977, Clinical and experimental immunology.